Cristina Capanni Selected Research

Proteins (Proteins, Gene)

1/2021	Ectopic Expression of Ankrd2 Affects Proliferation, Motility and Clonogenic Potential of Human Osteosarcoma Cells.
1/2020	Long term breeding of the Lmna G609G progeric mouse: Characterization of homozygous and heterozygous models.
1/2017	Emery-Dreifuss Muscular Dystrophy-Associated Mutant Forms of Lamin A Recruit the Stress Responsive Protein Ankrd2 into the Nucleus, Affecting the Cellular Response to Oxidative Stress.
10/2013	Changes in vimentin, lamin A/C and mitofilin induce aberrant cell organization in fibroblasts from Fanconi anemia complementation group A (FA-A) patients.
10/2012	Familial partial lipodystrophy, mandibuloacral dysplasia and restrictive dermopathy feature barrier-to-autointegration factor (BAF) nuclear redistribution.
4/2011	Laminopathies and lamin-associated signaling pathways.
6/2005	Altered pre-lamin A processing is a common mechanism leading to lipodystrophy.
5/2005	Laminopathies: involvement of structural nuclear proteins in the pathogenesis of an increasing number of human diseases.
12/2003	Dysferlin in a hyperCKaemic patient with caveolin 3 mutation and in C2C12 cells after p38 MAP kinase inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cristina Capanni Research Topics

Disease

15	Laminopathies 01/2020 - 05/2005
8	Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy) 01/2020 - 04/2003
7	Progeria (Hutchinson Gilford Syndrome) 01/2020 - 09/2009
6	Lipodystrophy 01/2021 - 06/2005
6	Familial Partial Lipodystrophy (Dunnigan Syndrome) 10/2012 - 11/2003
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2014 - 05/2005
3	Werner Syndrome (Werner's Syndrome) 07/2010 - 06/2005
2	Neoplasms (Cancer) 04/2022 - 01/2021
2	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 01/2008
2	Autosomal Emery-Dreifuss Muscular Dystrophy 01/2019 - 01/2017
2	Chromosomal Instability (Chromosome Stability) 01/2014 - 10/2013
2	Fanconi Anemia (Fanconi's Anemia) 01/2014 - 10/2013
2	Rare Diseases (Rare Disease) 07/2011 - 09/2009
1	Ewing Sarcoma (Sarcoma, Ewing) 04/2022
1	Carcinogenesis 01/2021
1	Kyphosis 01/2021
1	Inflammation (Inflammations) 01/2020
1	Bone Resorption 10/2015
1	Atherosclerosis 10/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2014
1	Bone Marrow Failure Disorders 01/2014
1	Hypersensitivity (Allergy) 10/2013
1	Cardiomyopathies (Cardiomyopathy) 06/2012
1	Osteolysis 07/2011
1	Muscular Dystrophies (Muscular Dystrophy) 04/2011
1	Heart Arrest (Cardiac Arrest) 11/2010
1	Cytomegalovirus Infections (Inclusion Disease) 03/2008
1	Infections 03/2008
1	Insulin Resistance 01/2007
1	Scleroatonic muscular dystrophy 01/2006
1	Muscular Diseases (Myopathy) 12/2003
1	Miyoshi myopathy 12/2003
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 12/2003

Drug/Important Bio-Agent (IBA)

20	Lamin Type A (Lamin A)IBA 04/2022 - 04/2003
12	prelamin AIBA 01/2020 - 06/2005
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2003
7	LaminsIBA 01/2019 - 11/2003
4	emerinIBA 01/2020 - 04/2003
4	ChromatinIBA 03/2016 - 10/2005
3	CytokinesIBA 01/2014 - 10/2013
2	Carrier Proteins (Binding Protein)IBA 01/2019 - 04/2011
2	HeterochromatinIBA 10/2015 - 01/2007
2	Lamin Type B (Lamin B)IBA 04/2011 - 03/2008
1	tocilizumab (atlizumab)FDA Link 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 03/2016
1	Sirolimus (Rapamycin)FDA Link 10/2015
1	Histones (Histone)IBA 10/2015
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2015
1	VimentinIBA 10/2013
1	Biological ProductsIBA 07/2011
1	lamina-associated polypeptide 2IBA 04/2011
1	Peptides (Polypeptides)IBA 04/2011
1	Nuclear Matrix-Associated ProteinsIBA 04/2011
1	Protein PrecursorsIBA 07/2010
1	Viral ProteinsIBA 03/2008
1	NF-kappa B (NF-kB)IBA 01/2008
1	Complementary DNA (cDNA)IBA 01/2008
1	CollagenIBA 01/2006
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2005
1	PPAR gammaIBA 06/2005
1	Nuclear Proteins (Protein, Nuclear)IBA 05/2005
1	DysferlinIBA 12/2003

Therapy/Procedure

2	Therapeutics 10/2015 - 02/2008
1	Induced Heart Arrest (Cardioplegia) 11/2010